NOVAVAX INC (NVAX) Stock Profile — Insider Trades & Financials

Revenue$147.1M

Net Income$17.5M

EPS$2.58

Market Cap$1.3B

Price Performance

Historical data including institutional events

Loading price data...

Company Profile

John C. Jacobs

CEO & Executive Director

Novavax, Inc., based in Gaithersburg, Maryland, develops vaccines to counter infectious diseases. The company developed the Novavax COVID-19 vaccine, now commercialized by Sanofi. The company also develops vaccines for influenza, respiratory syncytial virus (RSV), avian flu, shingles, Clostridioides difficile, and malaria.

Employees: 952
Headquarters: GAITHERSBURG, MD, United States
Website: www.novavax.com

Peer ComparisonRevenue ($B)

▾

⚡

Core Efficiency

ROE?

-13.72%

ROA?

1.49%

D/E Ratio?

-10.21

Op. Margin?

9.67%

📊

Profitability Ratios

Net Margin?

11.91%

Loading company sections...

NOVAVAX INC

Price Performance

Company Profile

Core Efficiency

Profitability Ratios

Core Efficiency

Profitability Ratios

Earnings Calendar

Data Freshness